Sarepta Therapeutics (SRPT) Q1 2023 Earnings Call Transcript
At this time, I'll turn the call over to Mary Jenkins, associate director, investor relations. Joining us on the call today are Doug Ingram, Ian Estepan, Dallan Murray, and Dr. After our formal remarks, we'll open the call for Q&A. I'd like to note that during this call, we'll be making a number of forward-looking statements.